These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 24991839)

  • 21. Safety and efficacy of decitabine in combination with temozolomide in metastatic melanoma: a phase I/II study and pharmacokinetic analysis.
    Tawbi HA; Beumer JH; Tarhini AA; Moschos S; Buch SC; Egorin MJ; Lin Y; Christner S; Kirkwood JM
    Ann Oncol; 2013 Apr; 24(4):1112-9. PubMed ID: 23172636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase I/II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanoma.
    Larkin JM; Hughes SA; Beirne DA; Patel PM; Gibbens IM; Bate SC; Thomas K; Eisen TG; Gore ME
    Br J Cancer; 2007 Jan; 96(1):44-8. PubMed ID: 17146474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase I study of erlotinib and hydroxychloroquine in advanced non-small-cell lung cancer.
    Goldberg SB; Supko JG; Neal JW; Muzikansky A; Digumarthy S; Fidias P; Temel JS; Heist RS; Shaw AT; McCarthy PO; Lynch TJ; Sharma S; Settleman JE; Sequist LV
    J Thorac Oncol; 2012 Oct; 7(10):1602-8. PubMed ID: 22878749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I and pharmacokinetic study of temozolomide on a daily-for-5-days schedule in patients with advanced solid malignancies.
    Hammond LA; Eckardt JR; Baker SD; Eckhardt SG; Dugan M; Forral K; Reidenberg P; Statkevich P; Weiss GR; Rinaldi DA; Von Hoff DD; Rowinsky EK
    J Clin Oncol; 1999 Aug; 17(8):2604-13. PubMed ID: 10561328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase I study of TPI 287 in combination with temozolomide for patients with metastatic melanoma.
    McQuade JL; Posada LP; Lecagoonporn S; Cain S; Bassett RL; Patel SP; Hwu WJ; Hwu P; Davies MA; Bedikian AY; Amaria RN
    Melanoma Res; 2016 Dec; 26(6):604-608. PubMed ID: 27540836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma.
    Barnard RA; Wittenburg LA; Amaravadi RK; Gustafson DL; Thorburn A; Thamm DH
    Autophagy; 2014 Aug; 10(8):1415-25. PubMed ID: 24991836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized phase I and pharmacological trial of sequences of 1,3-bis(2-chloroethyl)-1-nitrosourea and temozolomide in patients with advanced solid neoplasms.
    Hammond LA; Eckardt JR; Kuhn JG; Gerson SL; Johnson T; Smith L; Drengler RL; Campbell E; Weiss GR; Von Hoff DD; Rowinsky EK
    Clin Cancer Res; 2004 Mar; 10(5):1645-56. PubMed ID: 15014015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase I study of bortezomib and temozolomide in patients with advanced solid tumors.
    Portnow J; Frankel P; Koehler S; Twardowski P; Shibata S; Martel C; Morgan R; Cristea M; Chow W; Lim D; Chung V; Reckamp K; Leong L; Synold TW
    Cancer Chemother Pharmacol; 2012 Feb; 69(2):505-14. PubMed ID: 21850464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I study of vorinostat in combination with temozolomide in patients with high-grade gliomas: North American Brain Tumor Consortium Study 04-03.
    Lee EQ; Puduvalli VK; Reid JM; Kuhn JG; Lamborn KR; Cloughesy TF; Chang SM; Drappatz J; Yung WK; Gilbert MR; Robins HI; Lieberman FS; Lassman AB; McGovern RM; Xu J; Desideri S; Ye X; Ames MM; Espinoza-Delgado I; Prados MD; Wen PY
    Clin Cancer Res; 2012 Nov; 18(21):6032-9. PubMed ID: 22923449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I trial of weekly docetaxel and daily temozolomide in patients with metastatic disease.
    Tamaskar I; Mekhail T; Dreicer R; Olencki T; Roman S; Elson P; Bukowski RM
    Invest New Drugs; 2008 Dec; 26(6):553-9. PubMed ID: 18626572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II trial of arsenic trioxide and ascorbic acid with temozolomide in patients with metastatic melanoma with or without central nervous system metastases.
    Bael TE; Peterson BL; Gollob JA
    Melanoma Res; 2008 Apr; 18(2):147-51. PubMed ID: 18337652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase 1b study to assess the safety, tolerability, and clinical activity of pamiparib in combination with temozolomide in patients with locally advanced or metastatic solid tumors.
    Stradella A; Johnson M; Goel S; Park H; Lakhani N; Arkenau HT; Galsky MD; Calvo E; Baz V; Moreno V; Saavedra O; Luen SJ; Mu S; Wan Q; Chang V; Zhang W; Barve M
    Cancer Med; 2024 Jul; 13(13):e7385. PubMed ID: 38970256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I clinical trial of temozolomide and methoxyamine (TRC-102), an inhibitor of base excision repair, in patients with advanced solid tumors.
    Eads JR; Krishnamurthi SS; Saltzman J; Bokar JA; Savvides P; Meropol NJ; Gibbons J; Koon H; Sharma N; Rogers L; Pink JJ; Xu Y; Beumer JH; Riendeau J; Fu P; Gerson SL; Dowlati A
    Invest New Drugs; 2021 Feb; 39(1):142-151. PubMed ID: 32556884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II study of temozolomide (TMZ) and everolimus (RAD001) therapy for metastatic melanoma: a North Central Cancer Treatment Group study, N0675.
    Dronca RS; Allred JB; Perez DG; Nevala WK; Lieser EA; Thompson M; Maples WJ; Creagan ET; Pockaj BA; Kaur JS; Moore TD; Marchello BT; Markovic SN
    Am J Clin Oncol; 2014 Aug; 37(4):369-76. PubMed ID: 23357973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanoma.
    Kim KB; Hwu WJ; Papadopoulos NE; Bedikian AY; Camacho LH; Ng C; Hernandez IM; Frost AM; Jack MA; Hwu P
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):161-7. PubMed ID: 19002462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium study.
    Hummel TR; Wagner L; Ahern C; Fouladi M; Reid JM; McGovern RM; Ames MM; Gilbertson RJ; Horton T; Ingle AM; Weigel B; Blaney SM
    Pediatr Blood Cancer; 2013 Sep; 60(9):1452-7. PubMed ID: 23554030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: a randomized, phase III, multicenter study from the Dermatologic Cooperative Oncology Group.
    Kaufmann R; Spieth K; Leiter U; Mauch C; von den Driesch P; Vogt T; Linse R; Tilgen W; Schadendorf D; Becker JC; Sebastian G; Krengel S; Kretschmer L; Garbe C; Dummer R;
    J Clin Oncol; 2005 Dec; 23(35):9001-7. PubMed ID: 16260697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized trial of the combination of lomeguatrib and temozolomide compared with temozolomide alone in chemotherapy naive patients with metastatic cutaneous melanoma.
    Ranson M; Hersey P; Thompson D; Beith J; McArthur GA; Haydon A; Davis ID; Kefford RF; Mortimer P; Harris PA; Baka S; Seebaran A; Sabharwal A; Watson AJ; Margison GP; Middleton MR
    J Clin Oncol; 2007 Jun; 25(18):2540-5. PubMed ID: 17577032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temozolomide: the effect of once- and twice-a-day dosing on tumor tissue levels of the DNA repair protein O(6)-alkylguanine-DNA-alkyltransferase.
    Spiro TP; Liu L; Majka S; Haaga J; Willson JK; Gerson SL
    Clin Cancer Res; 2001 Aug; 7(8):2309-17. PubMed ID: 11489806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II multicentre study of temozolomide in combination with interferon alpha-2b in metastatic malignant melanoma.
    García M; del Muro XG; Tres A; Crespo C; Valladares M; López JJ; Rifà J; Pérez X; Filipovich E; Germà-Lluch JR
    Melanoma Res; 2006 Aug; 16(4):365-70. PubMed ID: 16845333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.